Jeffrey Davis
Founder at SCO Securities LLC
Jeffrey Davis active positions
Companies | Position | Start | End |
---|---|---|---|
SCO Capital Partners LLC
SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC. | Private Equity Investor | 2010-11-03 | - |
SCO Securities LLC | Founder | 2011-07-28 | - |
President | 1997-03-31 | - |
Career history of Jeffrey Davis
Former positions of Jeffrey Davis
Companies | Position | Start | End |
---|---|---|---|
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Director/Board Member | - | 2022-10-31 |
Chief Executive Officer | - | 2022-10-31 | |
President | - | 2022-10-31 | |
ABEONA THERAPEUTICS INC. | Director/Board Member | 2006-02-28 | 2017-05-14 |
Chief Executive Officer | 2007-12-25 | 2014-09-18 | |
Chief Operating Officer | 2015-01-18 | 2018-09-29 | |
Director of Finance/CFO | 2006-02-28 | - | |
President | 2006-02-28 | 2014-09-18 | |
Corporate Secretary | 2006-02-28 | - | |
Treasurer | 2006-02-28 | - | |
ULURU INC. | Director/Board Member | 2006-02-28 | 2015-11-30 |
Independent Dir/Board Member | 2006-02-28 | 2015-11-30 | |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Director/Board Member | 2004-12-31 | 2009-02-25 |
Oxford Ventures, Inc. | Director/Board Member | 2006-03-30 | 2006-04-04 |
HMSR, Inc.
HMSR, Inc. Medical SpecialtiesHealth Technology HMSR, Inc. developed products for blood transfusion and collection procedures. The company was founded by Eugene J. Zurlo and was headquartered in Boston, MA. | Director of Finance/CFO | - | - |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Director/Board Member | - | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Jeffrey Davis
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Boston University College of Engineering | Undergraduate Degree |
Statistics
International
United States | 17 |
United Kingdom | 2 |
Operational
Director/Board Member | 7 |
Director of Finance/CFO | 4 |
President | 4 |
Sectoral
Health Technology | 9 |
Finance | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
DEUTSCHE BANK AG | Finance |
ULURU INC. | Health Technology |
Private companies | 12 |
---|---|
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Health Technology |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Oxford Ventures, Inc. | Health Technology |
SCO Capital Partners LLC
SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC. | Finance |
SCO Securities LLC | |
SCO Financial Group LLC
SCO Financial Group LLC Investment Banks/BrokersFinance SCO Financial Group LLC operates a full service merchant bank, which is engaged in providing services to life sciences companies. It also offers fund management, investment banking and corporate partnering and licensing services to healthcare companies. The company was founded in 1997 and is headquartered in New York, NY. | Finance |
HMSR, Inc.
HMSR, Inc. Medical SpecialtiesHealth Technology HMSR, Inc. developed products for blood transfusion and collection procedures. The company was founded by Eugene J. Zurlo and was headquartered in Boston, MA. | Health Technology |
Deutsche Morgan Grenfell | Finance |
Bell Laboratories
Bell Laboratories Miscellaneous Commercial ServicesCommercial Services Bell Laboratories provides research and development services. It provides communications technologies including transistors, digital networking, signal processing, lasers and fiber-optic communications systems, communication satellites, cellular telephony, electronic switching of calls, touch-tone dialing and modems. The company was founded in 1925 and is headquartered in Murray Hill, NJ. | Commercial Services |
Virium Pharmaceuticals, Inc.
Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Health Technology |
Philips Medical Systems North America, Inc.
Philips Medical Systems North America, Inc. Medical SpecialtiesHealth Technology Part of Koninklijke Philips NV, Philips Medical Systems North America, Inc. is a private company that manufactures and wholesales diagnostic imaging systems and devices. The company is based in Bothell, WA. | Health Technology |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Part of Healthtech Solutions, Inc., Varian Biopharmaceuticals, Inc. is a private precision oncology company based in Naples, FL. Varian Bio is developing novel therapeutics for the treatment of cancer using precision oncology, which involves DNA testing to identify genetic mutations in tumors for more targeted treatment recommendations. Varian Bio's lead drug candidate, Var-101, is being developed in a topical formulation for the treatment of basal cell carcinoma, while Var-102, an oral formulation, is being developed for the treatment of various solid tumors, including non-small cell lung cancer, pancreatic cancer, and colorectal cancer. Varian Bio is also seeking additional precision oncology therapeutic candidates for its pipeline and exploring development collaborations. The CEO of the company is Jeffrey Blaine Davis. Varian Biopharmaceuticals was acquired by Healthtech Solutions, Inc. on May 07, 2021. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Davis
- Experience